AbbVie (ABBV) Price/FCF Ratio: History & Chart

AbbVie Inc.(ABBV)

Drug Manufacturers - General · North Chicago, IL

$250.27+1.49 (+0.60%)

Delayed quote: Sep 9, 2026, 10:00 AM EDT

About AbbVie Inc.

AbbVie Inc. is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of advanced medicines. Its extensive therapeutic portfolio encompasses several key areas: Immunology and Inflammation: Leading products include HUMIRA, an injectable therapy for autoimmune and intestinal Behçet's diseases; SKYRIZI, which addresses moderate to severe plaque psoriasis in adults; and RINVOQ, a JAK inhibitor for moderate to severe active rheumatoid arthritis in adult patients. Oncology and Hematology: For blood cancers, AbbVie provides IMBRUVICA and VENCLEXTA (a BCL-2 inhibitor), both indicated for adult patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). Virology: MAVYRET offers a treatment option for individuals with chronic HCV genotype 1-6 infection. Gastroenterology and Endocrinology: The company supplies CREON, an enzyme replacement therapy for exocrine pancreatic insufficiency, and Synthroid, used to manage hypothyroidism. Linzess/Constella helps treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation. Women's Health and Urology: Lupron serves as a palliative treatment for conditions like advanced prostate cancer, endometriosis, central precocious puberty, and anemia caused by uterine fibroids. ORILISSA, a nonpeptide small molecule GnRH antagonist, is designed for women experiencing moderate to severe endometriosis pain. Neurology: AbbVie offers Duopa and Duodopa, a levodopa-carbidopa intestinal gel for Parkinson's disease, and Ubrelvy to treat migraines (with or without aura) in adults. The therapeutic formulation of Botox is also part of its offerings. Ophthalmology: Its eye care segment features Lumigan/Ganfort (a bimatoprost ophthalmic solution) and Alphagan/Combigan (an alpha-adrenergic receptor agonist), both aimed at reducing elevated intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension. Restasis, a calcineurin inhibitor immunosuppressant, is provided to enhance tear production, alongside other specialized eye care products. AbbVie Inc. also engages in research collaborations, including a partnership with Dragonfly Therapeutics, Inc. The company was founded in 2012 and operates from its headquarters in North Chicago, Illinois.

North Chicago, IL

57,000 employees

www.abbvie.com

Healthcare / Drug Manufacturers - General

Sector: Healthcare
Industry: Drug Manufacturers - General
CEO: Robert A. Michael

View full financials

ABBV Price/FCF Ratio Metrics

PRICE/FCF RATIO

22.39

PRICE/FCF RATIO AVG TTM

20.46

PRICE/FCF RATIO AVG 3Y

17.91

PRICE/FCF RATIO AVG 5Y

15.30

PRICE/FCF RATIO AVG 10Y

14.11

PRICE/FCF RATIO AVG 15Y

14.84

PRICE/FCF RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

+9.42%

CURRENT VS 3Y AVG

+25.04%

CURRENT VS 5Y AVG

+46.37%

CURRENT VS 10Y AVG

+58.65%

CURRENT VS 15Y AVG

+50.88%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

21.55

median of 83 covered companies

CURRENT VS SECTOR MEDIAN

+3.90%

vs the sector median at left

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
AbbVie Inc. (ABBV)	$442.18B	22.39	20.46	17.91	15.30
Merck & Co., Inc. (MRK)vs ›	$367.24B	22.85	20.35	20.78	21.16
UnitedHealth Group Incorporated (UNH)vs ›	$345.58B	15.38	16.68	26.74	23.94
Roche Holding AG (RHHBY)vs ›	$345.60B	20.81	16.46	16.82	18.40
AstraZeneca PLC (AZN)vs ›	$246.27B	28.57	32.04	31.66	33.71
Johnson & Johnson (JNJ)vs ›	$649.81B	35.10	29.77	24.36	24.09
Thermo Fisher Scientific Inc. (TMO)vs ›	$223.06B	30.57	31.34	29.45	30.84
Amgen Inc. (AMGN)vs ›	$213.06B	21.02	19.68	20.07	18.28
Novo Nordisk A/S (NVO)vs ›	$200.85B	26.89	33.65	43.14	38.95
Abbott Laboratories (ABT)vs ›	$183.96B	21.09	26.85	32.87	29.55

NAME

MARKET CAP

PRICE/FCF RATIO

TTM

AbbVie Inc. (ABBV)

$442.18B

22.39

20.46

17.91

15.30

Merck & Co., Inc. (MRK)vs ›

$367.24B

22.85

20.35

20.78

21.16

UnitedHealth Group Incorporated (UNH)vs ›

$345.58B

15.38

16.68

26.74

23.94

Roche Holding AG (RHHBY)vs ›

$345.60B

20.81

16.46

16.82

18.40

AstraZeneca PLC (AZN)vs ›

$246.27B

28.57

32.04

31.66

33.71

Johnson & Johnson (JNJ)vs ›

$649.81B

35.10

29.77

24.36

24.09

Thermo Fisher Scientific Inc. (TMO)vs ›

$223.06B

30.57

31.34

29.45

30.84

Amgen Inc. (AMGN)vs ›

$213.06B

21.02

19.68

20.07

18.28

Novo Nordisk A/S (NVO)vs ›

$200.85B

26.89

33.65

43.14

38.95

Abbott Laboratories (ABT)vs ›

$183.96B

21.09

26.85

32.87

29.55

Price/FCF Ratio FAQ

What is the Price/FCF ratio for AbbVie Inc. (ABBV)?

The Price/FCF ratio for ABBV stock is 22.39.

Is AbbVie Inc.'s Price/FCF ratio high or low?

The Price/FCF ratio of 22.39 is 46% above its 5-year average of 15.30, near the high end of its 5-year range (9.45–23.93).

What is the TTM average Price/FCF ratio for AbbVie Inc. (ABBV)?

The TTM average Price/FCF ratio for ABBV stock is 20.46.

What is the 3Y average Price/FCF ratio for AbbVie Inc. (ABBV)?

The 3Y average Price/FCF ratio for ABBV stock is 17.91.

What is the 5Y average Price/FCF ratio for AbbVie Inc. (ABBV)?

The 5Y average Price/FCF ratio for ABBV stock is 15.30.

What is the 10Y average Price/FCF ratio for AbbVie Inc. (ABBV)?

The 10Y average Price/FCF ratio for ABBV stock is 14.11.

What is the 15Y average Price/FCF ratio for AbbVie Inc. (ABBV)?

The 15Y average Price/FCF ratio for ABBV stock is 14.84.

DATE	PRICE/FCF RATIO
2026-09-08	22.39
2026-09-04	23.08
2026-09-03	23.41
2026-09-02	23.55
2026-09-01	23.39
2026-08-31	23.07
2026-08-28	22.99
2026-08-27	23.23
2026-08-26	23.66
2026-08-25	23.92
2026-08-24	23.80
2026-08-21	23.84
2026-08-20	23.56
2026-08-19	23.93
2026-08-18	23.30
2026-08-17	22.52
2026-08-14	22.45
2026-08-13	22.57
2026-08-12	22.38
2026-08-11	22.50
2026-08-10	22.31
2026-08-07	22.14
2026-08-06	21.94
2026-08-05	22.15
2026-08-04	21.94
2026-08-03	22.05
2026-07-31	21.34
2026-07-30	21.89
2026-07-29	22.39
2026-07-28	22.38
2026-07-27	21.84
2026-07-24	22.05
2026-07-23	21.84
2026-07-22	21.54
2026-07-21	21.77
2026-07-20	21.54
2026-07-17	21.64
2026-07-16	21.63
2026-07-15	20.75
2026-07-14	20.81
2026-07-13	21.09
2026-07-10	21.09
2026-07-09	21.25
2026-07-08	21.49
2026-07-07	21.65
2026-07-06	21.66
2026-07-02	22.20
2026-07-01	21.35
2026-06-30	21.40
2026-06-29	21.62
2026-06-26	21.54
2026-06-25	20.67
2026-06-24	19.97
2026-06-23	19.96
2026-06-22	19.56
2026-06-18	18.41
2026-06-17	18.81
2026-06-16	18.92
2026-06-15	18.84
2026-06-12	19.36
2026-06-11	19.11
2026-06-10	19.13
2026-06-09	19.17
2026-06-08	18.97
2026-06-05	19.32
2026-06-04	19.13
2026-06-03	18.46
2026-06-02	18.31
2026-06-01	18.10
2026-05-29	18.51
2026-05-28	18.59
2026-05-27	18.31
2026-05-26	18.12
2026-05-22	18.34
2026-05-21	18.24
2026-05-20	18.05
2026-05-19	18.17
2026-05-18	17.80
2026-05-15	17.89
2026-05-14	17.92
2026-05-13	17.73
2026-05-12	17.67
2026-05-11	17.24
2026-05-08	17.14
2026-05-07	19.23
2026-05-06	19.45
2026-05-05	19.55
2026-05-04	19.75
2026-05-01	19.60
2026-04-30	20.05
2026-04-29	19.34
2026-04-28	18.75
2026-04-27	18.72
2026-04-24	18.85
2026-04-23	19.06
2026-04-22	19.02
2026-04-21	19.46
2026-04-20	19.32
2026-04-17	19.77
2026-04-16	19.83
2026-04-15	19.77
2026-04-14	19.95
2026-04-13	19.59
2026-04-10	19.73
2026-04-09	20.15
2026-04-08	20.07
2026-04-07	19.58
2026-04-06	19.61
2026-04-02	19.81
2026-04-01	20.39
2026-03-31	20.63
2026-03-30	20.22
2026-03-27	19.86
2026-03-26	20.03
2026-03-25	19.65
2026-03-24	19.47
2026-03-23	19.44
2026-03-20	19.45
2026-03-19	19.56
2026-03-18	19.76
2026-03-17	20.85
2026-03-16	21.01
2026-03-13	20.84
2026-03-12	21.38
2026-03-11	21.60
2026-03-10	21.53
2026-03-09	21.58
2026-03-06	21.83
2026-03-05	22.04
2026-03-04	22.41
2026-03-03	22.18
2026-03-02	22.22
2026-02-27	22.02
2026-02-26	21.31
2026-02-25	21.53
2026-02-24	21.67
2026-02-23	21.77
2026-02-20	21.33
2026-02-19	19.33
2026-02-18	19.70
2026-02-17	20.06
2026-02-13	19.94
2026-02-12	19.60
2026-02-11	19.02
2026-02-10	19.16
2026-02-09	19.23
2026-02-06	19.25
2026-02-05	18.87
2026-02-04	18.70
2026-02-03	19.44
2026-02-02	19.44
2026-01-30	19.21
2026-01-29	18.99
2026-01-28	18.84
2026-01-27	19.29
2026-01-26	19.02
2026-01-23	18.89
2026-01-22	18.79
2026-01-21	18.62
2026-01-20	18.44
2026-01-16	18.47
2026-01-15	18.67
2026-01-14	19.12
2026-01-13	19.02
2026-01-12	18.96
2026-01-09	18.96
2026-01-08	19.31
2026-01-07	20.11
2026-01-06	19.29
2026-01-05	18.97
2026-01-02	19.75
2025-12-31	19.68
2025-12-30	19.79
2025-12-29	19.89
2025-12-26	19.81
2025-12-24	19.80
2025-12-23	19.71
2025-12-22	19.63
2025-12-19	19.54
2025-12-18	19.20
2025-12-17	19.32
2025-12-16	19.27
2025-12-15	19.59
2025-12-12	19.24
2025-12-11	19.30
2025-12-10	19.40
2025-12-09	19.21
2025-12-08	19.22
2025-12-05	19.48
2025-12-04	19.70
2025-12-03	19.83
2025-12-02	19.33
2025-12-01	19.39
2025-11-28	19.62
2025-11-26	19.61
2025-11-25	19.97
2025-11-24	19.77
2025-11-21	20.36
2025-11-20	19.77
2025-11-19	20.06
2025-11-18	20.15
2025-11-17	20.16
2025-11-14	20.02
2025-11-13	20.01
2025-11-12	20.09
2025-11-11	19.40
2025-11-10	18.84
2025-11-07	18.88
2025-11-06	18.87
2025-11-05	18.67
2025-11-04	18.60
2025-11-03	20.59
2025-10-31	21.18
2025-10-30	22.17
2025-10-29	21.87
2025-10-28	22.11
2025-10-27	22.15
2025-10-24	22.15
2025-10-23	22.18
2025-10-22	22.22
2025-10-21	22.48
2025-10-20	22.55
2025-10-17	22.30
2025-10-16	22.04
2025-10-15	21.98
2025-10-14	22.26
2025-10-13	22.37
2025-10-10	22.39
2025-10-09	22.41
2025-10-08	22.47
2025-10-07	22.62
2025-10-06	22.36
2025-10-03	22.73
2025-10-02	22.98
2025-10-01	23.74
2025-09-30	22.50
2025-09-29	21.68
2025-09-26	21.43
2025-09-25	21.23
2025-09-24	21.37
2025-09-23	21.63
2025-09-22	21.63
2025-09-19	21.61
2025-09-18	21.57
2025-09-17	21.45
2025-09-16	21.01
2025-09-15	21.14
2025-09-12	21.21
2025-09-11	21.40
2025-09-10	20.56
2025-09-09	20.44
2025-09-08	20.38
2025-09-05	20.65
2025-09-04	20.69
2025-09-03	20.58
2025-09-02	20.59
2025-08-29	20.44
2025-08-28	20.20
2025-08-27	20.21
2025-08-26	20.24

DATE

PRICE/FCF RATIO

2026-09-08

22.39

2026-09-04

23.08

2026-09-03

23.41

2026-09-02

23.55

2026-09-01

23.39

2026-08-31

23.07

2026-08-28

22.99

2026-08-27

23.23

2026-08-26

23.66

2026-08-25

23.92

2026-08-24

23.80

2026-08-21

23.84

2026-08-20

23.56

2026-08-19

23.93

2026-08-18

23.30

2026-08-17

22.52

2026-08-14

22.45

2026-08-13

22.57

2026-08-12

22.38

2026-08-11

22.50

2026-08-10

22.31

2026-08-07

22.14

2026-08-06

21.94

2026-08-05

22.15

2026-08-04

21.94

2026-08-03

22.05

2026-07-31

21.34

2026-07-30

21.89

2026-07-29

22.39

2026-07-28

22.38

2026-07-27

21.84

2026-07-24

22.05

2026-07-23

21.84

2026-07-22

21.54

2026-07-21

21.77

2026-07-20

21.54

2026-07-17

21.64

2026-07-16

21.63

2026-07-15

20.75

2026-07-14

20.81

2026-07-13

21.09

2026-07-10

21.09

2026-07-09

21.25

2026-07-08

21.49

2026-07-07

21.65

2026-07-06

21.66

2026-07-02

22.20

2026-07-01

21.35

2026-06-30

21.40

2026-06-29

21.62

2026-06-26

21.54

2026-06-25

20.67

2026-06-24

19.97

2026-06-23

19.96

2026-06-22

19.56

2026-06-18

18.41

2026-06-17

18.81

2026-06-16

18.92

2026-06-15

18.84

2026-06-12

19.36

2026-06-11

19.11

2026-06-10

19.13

2026-06-09

19.17

2026-06-08

18.97

2026-06-05

19.32

2026-06-04

19.13

2026-06-03

18.46

2026-06-02

18.31

2026-06-01

18.10

2026-05-29

18.51

2026-05-28

18.59

2026-05-27

18.31

2026-05-26

18.12

2026-05-22

18.34

2026-05-21

18.24

2026-05-20

18.05

2026-05-19

18.17

2026-05-18

17.80

2026-05-15

17.89

2026-05-14

17.92

2026-05-13

17.73

2026-05-12

17.67

2026-05-11

17.24

2026-05-08

17.14

2026-05-07

19.23

2026-05-06

19.45

2026-05-05

19.55

2026-05-04

19.75

2026-05-01

19.60

2026-04-30

20.05

2026-04-29

19.34

2026-04-28

18.75

2026-04-27

18.72

2026-04-24

18.85

2026-04-23

19.06

2026-04-22

19.02

2026-04-21

19.46

2026-04-20

19.32

2026-04-17

19.77

2026-04-16

19.83

2026-04-15

19.77

2026-04-14

19.95

2026-04-13

19.59

2026-04-10

19.73

2026-04-09

20.15

2026-04-08

20.07

2026-04-07

19.58

2026-04-06

19.61

2026-04-02

19.81

2026-04-01

20.39

2026-03-31

20.63

2026-03-30

20.22

2026-03-27

19.86

2026-03-26

20.03

2026-03-25

19.65

2026-03-24

19.47

2026-03-23

19.44

2026-03-20

19.45

2026-03-19

19.56

2026-03-18

19.76

2026-03-17

20.85

2026-03-16

21.01

2026-03-13

20.84

2026-03-12

21.38

2026-03-11

21.60

2026-03-10

21.53

2026-03-09

21.58

2026-03-06

21.83

2026-03-05

22.04

2026-03-04

22.41

2026-03-03

22.18

2026-03-02

22.22

2026-02-27

22.02

2026-02-26

21.31

2026-02-25

21.53

2026-02-24

21.67

2026-02-23

21.77

2026-02-20

21.33

2026-02-19

19.33

2026-02-18

19.70

2026-02-17

20.06

2026-02-13

19.94

2026-02-12

19.60

2026-02-11

19.02

2026-02-10

19.16

2026-02-09

19.23

2026-02-06

19.25

2026-02-05

18.87

2026-02-04

18.70

2026-02-03

19.44

2026-02-02

19.44

2026-01-30

19.21

2026-01-29

18.99

2026-01-28

18.84

2026-01-27

19.29

2026-01-26

19.02

2026-01-23

18.89

2026-01-22

18.79

2026-01-21

18.62

2026-01-20

18.44

2026-01-16

18.47

2026-01-15

18.67

2026-01-14

19.12

2026-01-13

19.02

2026-01-12

18.96

2026-01-09

18.96

2026-01-08

19.31

2026-01-07

20.11

2026-01-06

19.29

2026-01-05

18.97

2026-01-02

19.75

2025-12-31

19.68

2025-12-30

19.79

2025-12-29

19.89

2025-12-26

19.81

2025-12-24

19.80

2025-12-23

19.71

2025-12-22

19.63

2025-12-19

19.54

2025-12-18

19.20

2025-12-17

19.32

2025-12-16

19.27

2025-12-15

19.59

2025-12-12

19.24

2025-12-11

19.30

2025-12-10

19.40

2025-12-09

19.21

2025-12-08

19.22

2025-12-05

19.48

2025-12-04

19.70

2025-12-03

19.83

2025-12-02

19.33

2025-12-01

19.39

2025-11-28

19.62

2025-11-26

19.61

2025-11-25

19.97

2025-11-24

19.77

2025-11-21

20.36

2025-11-20

19.77

2025-11-19

20.06

2025-11-18

20.15

2025-11-17

20.16

2025-11-14

20.02

2025-11-13

20.01

2025-11-12

20.09

2025-11-11

19.40

2025-11-10

18.84

2025-11-07

18.88

2025-11-06

18.87

2025-11-05

18.67

2025-11-04

18.60

2025-11-03

20.59

2025-10-31

21.18

2025-10-30

22.17

2025-10-29

21.87

2025-10-28

22.11

2025-10-27

22.15

2025-10-24

22.15

2025-10-23

22.18

2025-10-22

22.22

2025-10-21

22.48

2025-10-20

22.55

2025-10-17

22.30

2025-10-16

22.04

2025-10-15

21.98

2025-10-14

22.26

2025-10-13

22.37

2025-10-10

22.39

2025-10-09

22.41

2025-10-08

22.47

2025-10-07

22.62

2025-10-06

22.36

2025-10-03

22.73

2025-10-02

22.98

2025-10-01

23.74

2025-09-30

22.50

2025-09-29

21.68

2025-09-26

21.43

2025-09-25

21.23

2025-09-24

21.37

2025-09-23

21.63

2025-09-22

21.63

2025-09-19

21.61

2025-09-18

21.57

2025-09-17

21.45

2025-09-16

21.01

2025-09-15

21.14

2025-09-12

21.21

2025-09-11

21.40

2025-09-10

20.56

2025-09-09

20.44

2025-09-08

20.38

2025-09-05

20.65

2025-09-04

20.69

2025-09-03

20.58

2025-09-02

20.59

2025-08-29

20.44

2025-08-28

20.20

2025-08-27

20.21

2025-08-26

20.24

Price/FCF Ratio: 22.39

ABBV Price/FCF Ratio Chart

ABBV Average Price/FCF Ratio Chart

ABBV Current vs Average Price/FCF Ratio Chart

ABBV Price/FCF Ratio Metrics

ABBV Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

Price/FCF Ratio FAQ

ABBV Price/FCF Ratio History

Related Metrics